34P Treatment sequencing in the VISION study of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC

Autor: F. Griesinger, M.C. Garassino, E. Felip, H. Sakai, X. Le, R. Veillon, E.F. Smit, J. Raskin, M. Thomas, M-J. Ahn, S. Vlassak, R. Bruns, A. Johne, P.K. Paik

Publikováno v: Journal of Thoracic Oncology. 18:S60-S61

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f7d4f3a5f231e16b590202a6b4a865c
https://doi.org/10.1016/s1556-0864(23)00288-5

364P Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series

Autor: A.R. Ahmad, L.M. Tho, Y.K.J. Chik, W.C.K. Lee, T-Y. Yang, X. Le, A.K. Eisert, U. Himpe, C. De Bondt, J. Mazieres, I. Petrini, W-S. Lam, K. Joshi, K. Berghoff, S. Vlassak, N. Karachaliou, A.J. Van Der Wekken, T-C. Hsia

Publikováno v: Annals of Oncology. 33:S1584

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afcd8aab104770d59b7d096c1000a616
https://doi.org/10.1016/j.annonc.2022.10.402

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PD-005 Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma

Autor: Arne Wenz, Baek-Yeol Ryoo, A-L Cheng, Markus Peck-Radosavljevic, A. Deptala, Daniel H. Palmer, Paul Ross, Laetitia Fartoux, Yin-Hsun Feng, Arsene-Bienvenu Loembe, Deng-Yn Lin, Julia Hocke, Y.T. Ma, Yee Chao, C.-J. Yen, S. Vlassak, Janet Graham, Tim Meyer

Publikováno v: Annals of Oncology. 26:iv102

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51e7b5a04e56dcea412dfde0a7df68f0
https://doi.org/10.1093/annonc/mdv234.04

Risk of Major Bleeding in Cancer Patients Receiving Chemotherapy

Autor: J. Kim, M. Naghiby Sustany, Connie Chen, A. Ruiz-Valdepeñas, S. Perrin, A. Chaslerie, C. Terret, Nichole Young-Lin, K. Kim, H. Hoeffkes, M. Carvalho-Verlinde, L.C. Park, M. Kroez, Omneya Hassanain, T. van Gelder, L. Xiong, T.K. Kiet, S. Dacosta Byfield, J. Goswami, C.K. Bose, H. Bourgeois, J. Metges, A. Fani Pakdel, L. Marelli, Y. Lou, D.S. Kapp, S. Bercier, E. Lugatti, A. Costantini, R.P. Riechelmann, S. Patel, Q. Dong, J. Finek, H. Ghazal, K. Chatterjee, B. Chatterjee, G. Fasola, Z. Hu, E. Minvielle, S. J. Mukhopadhyay, W.K. Redekop, S. Abouelnaga, J.K. Chan, P. Pronzato, R. Laporta, J.H. Zong, Gary H. Lyman, M. Ghielmini, D.H.S. Brundel, A. Zimmermann, Jun Suk Kim, R. Barroso-Sousa, J. Ma, P.M. Hoff, W. Baumann, S. Banerjee, U.R. Kleeberg, François Lemare, F.K. Tauchert, M. Hipp, C. Atchison, Y. Tang, J. Menis, C. Locher, B. Cantos, S. Nawrocki, L. Zhang, E. De Droogh, M. Irwin, P. Das, G.A.M.S. (Guus) van Dongen, S.K. Sarkar, A. Olaverri Hernandez, R.W.F. van Leeuwen, G. Hebert, P. Martin Martorell, F.G.A. Jansman, A. Fourcade, B.K. Mohanti, H.J. Conter, G. Streich, J. Piquet, G. Iacono, P. Bycott, C. Bighin, C. Pedrazzani, A. Carrato, JA Santiago Crespo, A. Baitar, S. Pizzolitto, D. Debieuvre, O. Gunther, T. Collon, E. Jaeger, B. Han, I. Duran, L. Testa, M. Lambertini, J. Gutsch, J.W. Lee, D. Galdermans, S. Negrier, D. Mauri, N. Nakayama, K. Veerabudun, T. Teague, G. Spahn, M. Jofre-Bonet, Z. Brixi, M. Maglakelidze, H. Li, R. Ferreira, H. Ryu, R. Zaim, L.H. Martinez, D. Lorusso, R. Cardiga, J. Liu, F. Poggio, C. Herbstreit, M. Rezazadeh, R. von Moos, J. Pivette, J. Mebis, F. Ceia, A. Ohtsu, A. Le Thuaut, F. Blanchon, M. Weber, V. Tozzi, F. van Fraeyenhove, A.C.R.C. Ferrari, D-W. Ye, D. Pastorelli, M. Gaiardo, L. Gurrieri, S. Al-Batran, R. Eckert, A. Happe, L. Del Mastro, M.V. Karamouzis, W. Hwu, R. Li, A. Zhou, V. Petry Helena, C. Neef, J.R. Puyol, M. Laurent, C. Ortega Ruiperez, G. D'Addario, C. Fonseca, R. de Bree, M. Zaegel, M. Provencio Pulla, Sabine Tejpar, G. Rosti, L. De Fiore, Y.J. Choi, M. Fink, E. Terpos, M. Precivale, T.K. Takahashi, Tetsuji Takayama, David M. Burger, J. Feliu, M. Debus, K. Tamas, C.A. Uyl-de Groot, A. Voigt, C. Fu, E. Molinas, C. Maximiano, L. Eckert, C.O. Ruiperez, D. Bertwistle, T. Mossman, A. De Maria, C.T. Carvalho, V. Raina, C. Guillen-Ponce, H. Matthes, Arijit Mukhopadhyay, M. Muñoz Sanchez, G.M. Bariani, D. Pérez Callejo, J. Lebreton, D. Hoth, Florence Netzer, E. Liuu, A. Leitão, P. Ussetti, A. Gu, A.C. Palozzo, N. Maniadakis, Sameera Ezzat, L.G. Fonseca, E. Bria, A.T. Cohen, E.J. Batagelj, T. Yoshino, M. Sabry, A. Jirillo, N. Papadopolous, N. Cherny, I. Amanam, M. Tettamanti, J. Axtner, M.S. Mano, P. Rescigno, D. Conter, T. Tanase, S.K. Mondal, M. Blanco Villalba, Sung Heon Kim, G. Lanzetta, M. Palka, F. Schad, A. Small, D. Lueftner, R. Arai, O. Mora, Jayasri Basak, S. Piau, A. Mahmood, M. Mendez Garcia, D. Romeira, A.M. Martins, S. Schmitz, Y. Huang, S. Imbevaro, N. Marschner, Svs Deo, Ron H.J. Mathijssen, E. Meszko, F. Lobo, E. Ferrat, F. Martin, Johan Vansteenkiste, M. Molina-Garido, M.P. Mak, R.E. Buschmann-Maiworm, I. Bourlaud, A. Bedikian, Ahmad S. Alfaar, R. De Paula Costa, T. Denda, P. Anderson, J. Quidde, J. Lake, Ajay Gogia, M. Grivaux, S-H Lee, S. Vlassak, M.P. Bramajo, C. El Kouri, P. Quadri, Young-Suk Park, P. Donny, S. Gangopadhyay, A. Follador, Francesca Valent, W.S. Dai, E. Almagro Casado, S. Giraudi, J. Guo, A. Pini, M.P. Trojniak, R. Curca, M. Proença, Mohamed Kamal, M. Le Poulain-Doubliez, A. D'Alonzo, J. Pereira, N. Jokhadze, M. Di Maio, H. Hoefeler, C. Rossetto, C. Reyes, C. Hamada, E. Paillaud, Josep Tabernero, R. Gagua, C. Attali, H. Sleeboom, A. Vandebroek, G. Hechmati, J. Body, R. Wei, S. Culine, Fortunato Ciardiello, Robert A. Wolff, R. Hofheinz, P. Caillet, M.L. Gomez, Michel Ducreux, M. Rucinska, P. Hwu, A. Bahl, W. Chang, J. Douillard, Hirofumi Fujii, A. Kieszkowska-Grudny, M. Alface, F. Grude, B.J. Monk, F. Canouï-Poitrine, Nootan Kumar Shukla, A. Levaggi, D. Schrijvers, M. Urbanski, S. Rauh, S. Bastuji-Garin

Publikováno v: Annals of Oncology. 23:ix447

Cancer patients receiving chemotherapy are at increased risk of venous thromboembolism (VTE). The presence of cancer and anticoagulant use are risk factors for bleeding, yet data on bleeding risk are limited in these patients. This analysis evaluated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::65631e191932d84667ee1fa2bb6bf709
https://doi.org/10.1093/annonc/mds410